Dithiocarbamate complexes as radiopharmaceuticals for medical imaging

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 12, 2012, Pages 1174-1183

  Berry, David J ^a   Torres Martin de Rosales, Rafael ^a   Charoenphun, Putthiporn ^a   Blower, Philip J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Copper; Dithiocarbamate; Nuclear medicine; Radiopharmaceuticals; Rhenium; Technetium

Indexed keywords

BISMUTH 212; BISMUTH 213; BISMUTH DERIVATIVE; CIPROFLOXACIN; COBALT COMPLEX; COPPER 64; COPPER COMPLEX; DIETHYLDITHIOCARBAMIC ACID; DIETHYLDITHIOCARBAMIC ACID TL 201; DIMETHYLDITHIOCARBAMIC ACID; DIMETHYLDITHIOCARBAMIC ACID CU 64; DITHIOCARBAMIC ACID DERIVATIVE; GARENOXACIN; GATIFLOXACIN; GOLD 195; METAL COMPLEX; MOLYBDENUM 99; MOXIFLOXACIN; NITRIDOCADE TECHNETIUM TC 99M; NORFLOXACIN; RADIOPHARMACEUTICAL AGENT; RHENIUM 186; RHENIUM 188; RHENIUM COMPLEX; SITAFLOXACIN; TECHNETIUM 99M; THALLIUM 201; TOSUFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; COMPLEX FORMATION; DIAGNOSTIC IMAGING; DRUG HALF LIFE; DRUG STRUCTURE; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY;

BISMUTH; COBALT; COORDINATION COMPLEXES; COPPER; DIAGNOSTIC IMAGING; GOLD; HUMANS; RADIOPHARMACEUTICALS; RHENIUM; TECHNETIUM; THALLIUM; THIOCARBAMATES;

EID: 84866453584     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712802762112     Document Type: Article

References (103)

1. Heard, P.J. Main group dithiocarbamate complexes. Prog. Inorg. Chem., 2005, 53, 1-69.
2. Hogarth, G. Transition Metal Dithiocarbamates: 1978-2003. Prog. Inorg. Chem., 2005, 53, 71-561.
3. Jurisson, S.; Berning, D.; Jia, W.; Ma, D. Coordination compounds in nuclear medicine, Chem. Rev., 1993, 93, 1137-1156.
4. 188ReO4]-. Nucl. Med. Biol., 2003, 30, 381-387.
5. Pojer, P. M.; Baldas, J. Technetium-99m-labelled N,Ndiethyldithiocarbamate - A non-polar complex with slow hepatic clearance. Int. J. Nucl. Med. Biol., 1981, 8, 112-114.
6. de Bruine, J. F.; van Royen, E. A.; Vyth, A.; de Jong, J. M. B. V.; van der Schoot, J. B. Thallium-201 diethyldithiocarbamate: An alternative to iodine-123 N-isopropyl-p-iodoamphetamine. J. Nucl. Med., 1985, 26, 925-930.
7. Ballinger, J. R.; Gerson, B.; Gulenchyn, K. Y. Technetium-99m diethyldithiocarbamate (DDC): Comparison with thallium-201 DDC as an agent for brain imaging. Int. J. Radiat. Appl. Instrum. Part A. Appl. Rad. Isot., 1987, 38, 665-668.
8. Sampson, C. B.; Solanki, C. Technetium-labeled leukocytes using diethyldithiocarbamate - preliminary-report on in vitro studies. Nucl. Med. Commun., 1988, 9, 123-127.
9. Stalteri, M. A.; Parrott, S. J.; Griffiths, V. A.; Dilworth, J. R.; Mather, S. J. Uptake of Tc-99m-nitrido dithiocarbamate complexes by tumour cells. Nucl. Med. Commun., 1997, 18, 870-877.
10. 99mTc-nitrido dithiocarbamate complexes as brain perfusion imaging agent. Appl. Rad. Isot., 2006, 64, 361-367.
11. 99mTc nitride dithiocarbamate complexes containing heterocyclic linkage as potential brain perfusion imaging agents. J. Radioanal. Nucl. Chem., 2007, 274, 195-197.
12. 99mTcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging. Bioorg. Med. Chem. Lett., 2008, 18, 5168-5170.
13. 99mTc(CO)3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection. Bioorg. Med. Chem. Lett., 2010, 20, 3781-3784.
14. Joris, S. J.; Aspila, K. I.; Chakrabarti, C. I. Decomposition of monoalkyl dithiocarbamates. Anal. Chem., 1970, 42, 647-651.
15. Marchi, A.; Marchesi, E.; Marvelli, L.; Bergamini, P.; Bertolasi, V.; Ferretti, V. New Water-Soluble Rhenium Complexes with 1,3,5-Triaza-7-phosphaadamantane (PTA) - X-ray Crystal Structures of [ReNCl2(PTA)3], [ReO2Cl(PTA)3], [ReCl3(PTA)2(PPh3)], and [Re2N2Cl3(Et2dtc)(PTA)4]. Eur. J. Inorg. Chem., 2008, 2670-2679.
16. + (tad = 1,5,8,12-Tetraazadodecane). Inorg. Chem., 1990, 29, 2091-2096.
17. Rowbottom, J.; Wilkinson, G. Dithiocarbamate Complexes of Rhenium(V) and (III). J. Chem. Soc., Dalton Trans., 1972, 826-830.
18. Fletcher, S. R.; Skapski, A. C. Crystal and Molecular Structure of Square-Pyramidal Complex Nitridobis(N,NDiethyldithiocarbamato) Rhenium(V). J. Chem. Soc., Dalton Trans., 1972, 1079-1082.
19. Baldas, J.; Bonnyman, J.; Pojer, P. M.; Williams, G. A.; Mackay, M. F. Synthesis and Structure of Bis(Diethyldithiocarbamato) Nitridotechnetium(V) - a Technetium-Nitrogen Triple Bond. J. Chem. Soc., Dalton Trans., 1981, 1798-1801.
20. Chatt, J.; Garforth, J. D.; Johnson, N. P.; Rowe, G. A. Nitrido- and arylimido-complexes of rhenium. J. Chem. Soc. (Resumed)., 1964, 1012-1020.
21. Pasqualini, R.; Duatti, A.; Bellande, E.; Comazzi, V.; Brucato, V.; Hoffschir, D.; Fagret, D.; Comet, M. Bis(Dithiocarbamato) Nitrido Technetium-99m Radiopharmaceuticals: A Class of Neutral Myocardial Imaging Agents. J. Nucl. Med., 1994, 35, 334-341.
22. Auzeloux, P.; Papon, J.; Masnada, T.; Borel, M.; Moreau, M.-F.; Veyre, A.; Pasqualini, R.; Madelmont, J.-C. Synthesis and biodistribution of technetium-99m-labelled N-(diethylaminoethyl) benzamide via a bis(dithiocarbamate) nitridotechnetium(V) complex. J. Labelled Compd. Radiopharm., 1999, 42, 325-335.
23. 99mTc-complexes as potential agents for targeting hypoxia. Bioorg. Med. Chem. Lett., 2011, 21, 394-397.
24. 99mTc nitrido complex with 2-(4-nitro-1Himidazolyl) ethyl dithiocarbamate (NIET). J. Radioanal. Nucl. Chem., 2004, 261, 199-202.
25. 99mTc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake. Bioorg. Med. Chem. Lett., 2009, 19, 2752-2754.
26. 99mTc-labelling and evaluated as potential 5-HT1A receptor imaging agents. Science China Chem., 2011, 54, 1148-1154.
27. Chatt, J.; Rowe, G. A. Complex compounds of tertiary phosphines and a tertiary arsine with rhenium(V), rhenium(III), and rhenium(II). J. Chem. Soc. (Resumed)., 1962, 4019-4033.
28. Sullivan, B. P.; Brewer, J. C.; Gray, H. B.; Linebarrier, D.; Mayer, J. M. in Inorg. Synth., John Wiley & Sons, 2007; pp. 146-150.
29. 99mTcN(noet)2] (noet =N-Ethyl-N-Ethoxydithiocarbamato). J. Chem. Soc., Chem. Commun., 1992, 1354-1355.
30. Ghezzi, C.; Fagret, D.; Arvieux, C. C.; Mathieu, J.-P.; Bontron, R.; Pasqualini, R.; de Leiris, J.; Comet, M. Myocardial Kinetics of TcN-NOET: A Neutral Lipophilic Complex Tracer of Regional Myocardial Blood Flow. J. Nucl. Med., 1995, 36, 1069-1077.
31. Jeetley, P.; Sabharwal, N. K.; Soman, P.; Kinsey, C.; Raval, U.; Bhonsle, U.; Lahiri, A. Comparison between Tc-99m N-NOET and Tl-201 in the assessment of patients with known or suspected coronary artery disease. J. Nucl. Cardiol., 2004, 11, 664-672.
32. Fagret, D.; Marie, P.-Y.; Brunotte, F.; Giganti, M.; Le Guludec, D.; Bertrand, A.; Wolf, J.-E.; Piffanelli, A.; Chossat, F.; Bekhechi, D.; Pasqualini, R.; Machecourt, J.; Comet, M. Myocardial Perfusion Imaging with Technetium-99m-N-NOET: Comparison with Thallium-201 and Coronary Angiography. J. Nucl. Med., 1995, 36, 936-943.
33. Uccelli, L.; Giganti, M.; Duatti, A.; Bolzati, C.; Pasqualini, R.; Cittanti, C.; Colamussi, P.; Piffanelli, A. Subcellular Distribution of Technetium-99m-N-NOEt in Rat Myocardium. J. Nucl. Med., 1995, 36, 2075-2079.
34. 2] derivatives. J. Labelled. Compd. Radiopharm., 1998, 41, 863-869.
35. 99mTcN(NOET)2], NOET = Et(EtO)NCS2: Their In Vitro Localization and Chemical Behaviour. Nucl. Med. Biol., 1997, 24, 701-705.
36. 99mTc nitrido complex for brain imaging. Appl. Rad. Isot., 2001, 54, 745-748.
37. 99mTc nitrido complex for cerebral imaging. Nucl. Med. Biol., 2002, 29, 665-669.
38. 99mTcN(IPDTC)2 and its biodistribution in mice. J. Radioanal. Nucl. Chem., 2001, 249, 573-576.
39. 99mTcN(PDTC)2 as a potential brain imaging agent. J. Radioanal. Nucl. Chem., 2004, 262, 505-507.
40. 99mTc complex: A potential new brain imaging agent. J. Radioanal. Nucl. Chem., 2007, 273, 15-17.
41. 99mTc complex: a potential new radiopharmaceutical for brain perfusion studies. Appl. Radiat. Isot., 2005, 62, 33-37.
42. 99mTc nitrido dithiocarbamate complex containing aromatic group for cerebral imaging. Appl. Radiat. Isot., 2010, 68, 101-104.
43. 99mTc nitrido complex for brain imaging. J. Labelled. Compd. Radiopharm., 2004, 47, 647-655.
44. 99mTc nitrido complex as a potential brain perfusion imaging agent. J. Labelled. Compd. Radiopharm., 2000, 43, 693-700.
45. Zhang, J. B.; Luo, G.; Wang, X. B. Synthesis and biodistribution of a novel Tc-99m nitrido dithiocarbamate complex containing ether group as a potential myocardial and brain imaging agent. J. Radioanal. Nucl. Chem., 2009, 279, 783-785.
46. 99mTc nitrido complex as a potential myocardial and cerebral imaging agent. Appl. Radiat. Isot., 2002, 56, 857-861.
47. 99mTcN(CHIPDTC)2 as a potential myocardial perfusion imaging agent. J. Radioanal. Nucl. Chem., 2002, 254, 99-101.
48. 99mTcN Complex of Norfloxacin Dithiocarbamate as a Potential Agent for Bacterial Infection Imaging. Bioconj. Chem., 2011, 22, 369-375.
49. Shah, S.; Khan, A.; Khan, M. Radiosynthesis and biodistribution of (TcN)-Tc-99m-Garenoxacin dithiocarbamate complex a potential infection imaging agent. J. Radioanal. Nucl. Chem., 2011, 288, 59-64.
50. 99mTcN-trovafloxacin dithiocarbamate: a novel methicillin-resistant Staphylococcus aureus infection imaging agent. J. Radioanal. Nucl. Chem., 2011, 288, 215-220.
51. 99mTcN-moxifloxacin dithiocarbamate, as a potential radiopharmaceutical for scintigraphic localization of infectious foci. J. Radioanal. Nucl. Chem., 2011, 288, 357-362.
52. 99mTc(CO)3-tosufloxacin dithiocarbamate complexation and radiobiological evaluation in male Wistar rat model. J. Radioanal. Nucl. Chem., 2011, 288, 485-490.
53. 99mTcN-sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection. J. Radioanal. Nucl. Chem., 2011, 287, 827-832.
54. 99mTcN-gatifloxacin dithiocarbamate complex: a novel multi-drug-resistance Streptococcus pneumoniae (MRSP) infection radiotracer. J. Radioanal. Nucl. Chem., 2011, 289, 903-908.
55. 99mTcN-4- (cyclohexylpiperazin-1-yl)-dithioformate as a potential sigma receptor imaging agent. J. Labelled. Compd. Radiopharm., 2007, 50, 1200-1205.
56. 2+ (PXP = Diphosphine Ligand). A Novel Tool for the Selective Labeling of Small Molecules. J. Am. Chem. Soc., 2002, 124, 11468-11479.
57. 99Tc, Re; DTC = Dithiocarbamate; PNP = Heterodiphosphane). Eur. J. Inorg. Chem., 2004, 1902-1913.
58. Marotta, E.; Tisato, F.; Refosco, F.; Bolzati, C.; Porchia, M.; Traldi, P. Electrospray ionization mass spectrometry in the structural characterization of a mixed nitrido-Tc heterocomplex of interest for myocardial imaging. Rapid Commun. Mass Spectrom., 2003, 17, 1225-1228.
59. Tubaro, M.; Marotta, E.; Traldi, P.; Bolzati, C.; Porchia, M.; Refosco, F.; Tisato, F. ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes. Int. J. Mass Spectrom., 2004, 232, 239-247.
60. Boschi, A.; Bolzati, C.; Uccelli, L.; Duatti, A.; Benini, E.; Refosco, F.; Tisato, F.; Piffanelli, A. A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties. Nucl. Med. Commun., 2002, 23, 689-693.
61. 99mTc-Nitride Heterocomplexes Showing High Heart Uptake and Improved Imaging Properties. J. Nucl. Med., 2003, 44, 806-814.
62. 99mTc-Tetrofosmin in Rats. J. Nucl. Med., 2004, 45, 2095-2101.
63. 99mTcN(PNP5)(NOEt)]+: A novel potential myocardial perfusion imaging agent. J. Radioanal. Nucl. Chem., 2006, 269, 175-179.
64. 99mTc-nitrido complex of metronidazole derivative. J. Labelled Compd. Radiopharm., 2007, 50, 1137-1142.
65. 2+ Metal Fragments (M = Tc, Re; PXP = Diphosphine Ligand). Inorg. Chem., 2004, 43, 8617-8625.
66. 99mTc-N-DBODC. J. Nucl. Med., 2008, 49, 1299-1304.
67. 99mTc(N)(DTC-Ln)(PNP)]+ Complex (DTC-Ln = Alicyclic Dithiocarbamate and PNP = Diphosphinoamine). Bioconj. Chem., 2010, 21, 928-939.
68. 99mTc-Labeling of Small Biomolecules. Bioconj. Chem., 2006, 17, 473-484.
69. 99mTc complexes useful as radiopharmaceuticals for heart imaging. Dalton. Trans., 2007, 1183-1193.
70. Bolzati, C.; Cavazza-Ceccato, M.; Agostini, S.; Tisato, F.; Bandoli, G. Technetium and Rhenium in Five-Coordinate Symmetrical and Dissymmetrical Nitrido Complexes with Alkyl Phosphino-thiol Ligands. Synthesis and Structural Characterization. Inorg. Chem., 2008, 47, 11972-11983.
71. 99mTc Compounds as Potential Brain Imaging Agents. Bioconj. Chem., 2006, 17, 419-428.
72. Bolzati, C.; Salvarese, N.; Carta, D.; Refosco, F.; Dolmella, A.; Pietzsch, H.; Bergmann, R.; Bandoli, G. Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2- methoxyphenylpiperazine dithiocarbamate derivatives as an example. J. Biol. Inorg. Chem., 2011, 16, 137-155.
73. 99mTc, Re) fragment to biomolecules. J. Organomet. Chem., 2004, 689, 4757-4763.
74. 99mTc- and 188Re-Radiopharmaceutical Applications. Eur. J. Inorg. Chem., 2005, 4048-4055.
75. 99mTc(CO)3-DEDT complex as a potential new radiopharmaceutical for brain imaging. J. Radioanal. Nucl. Chem., 2007, 272, 91-94.
76. 99mTc(CO)3-sitafloxacin dithiocarbamate complex: a promising Staphylococcus aureus infection radiotracer. J. Radioanal. Nucl. Chem., 2011, 288, 131-136.
77. Cowley, A. R.; Dilworth, J. R.; Donnelly, P. S.; Ross, S. J. Rhenium diazenide ternary complexes with dithiocarbamate ligands: towards new rhenium radiopharmaceuticals. Dalton. Trans., 2007, 73-82.
78. Fletcher, S. R.; Skapski, A. C. Crystal and molecular structure of carbonyltris(N,N-diethyldithiocarbamato)rhenium(III): a complex of seven-co-ordinate rhenium. J. Chem. Soc., Dalton. Trans., 1974, 486-489.
79. Baldas, J.; Bonnyman, J.; Pojer, P. M.; Williams, G. A.; Mackay, M. F. Preparation and crystal structure of carbonyltris(diethyldithiocarbamato) technetium(III): an unexpected source of co-ordinated carbon monoxide. J. Chem. Soc., Dalton. Trans., 1982, 451-455.
80. 99mTc-carbonyl dithiocarbamates showing rapid hepatobiliary excretion. Int. J. Rad. Appl. Instrum. B. Nucl. Med. Biol., 1992, 19, 741-746.
81. Baldas, J.; Bonnyman, J.; Mackay, M. F.; Williams, G. A. Structural studies of technetium complexes v. The preparation and crystal structure of dichlorobis(diethyldithiocarbamato)- thionitrosyltechnetium(III). Aust. J. Chem., 1984, 37, 751-759.
82. Baldas, J.; Colmanet, S. F.; Williams, G. A. Preparation and structure of dibromobis(N,N-diethyldithiocarbamato)- thionitrosyltechnetium(III). Aust. J. Chem., 1991, 44, 1125-1132.
83. Wadas, T. J.; Wong, E. H.; Weisman, G. R.; Anderson, C. J. Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease. Chem. Rev., 2010, 110, 2858-2902.
84. 62Cu generator. Radioisotopes., 1990, 39, 482-486.
85. Dearling, J. L. J.; Mullen, G. E. D.; Lewis, J. S.; Welch, M. J.; Blower, P. J. Dithiocarbamate copper complexes as blood flow tracers. J. Labelled Compd. Radiopharm., 1999, 42, 835.
86. Charoenphun, P. R.; Paul, R.; Weeks, A.; Berry, D.; Shaw, K.; Mullen, G.; Ballinger, J.; Blower, P. PET tracers for cell labeling with the complexes of copper 64 with lipophilic ligands. Eur. J. Nucl. Med. Mol. Imaging, 2011, 38, S294-S294.
87. Torres Martin de Rosales, R.; Tavaré, R.; Paul, R. L.; Jauregui-Osoro, M.; Protti, A.; Glaria, A.; Varma, G.; Szanda, I.; Blower, P. J. Synthesis of 64CuII-Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In:Vivo Evaluation as Dual-Modality PET-MRI Agent. Angew. Chem. Int. Ed., 2011, 50, 5509-5513.
88. Lear, J. L.; Navarro, D. Autoradiographic Comparison of Thallium- 201 Diethyldithiocarbamate, Isopropyliodoamphetamine and Iodoantipyrine as Cerebral Blood Flow Tracers. J. Nucl. Med., 1987, 28, 481-486.
89. Limburg, M.; van Royen, E. A.; Hijdra, A.; Verbeeten, B. RCBFSPECT in Brain Infarction: When Does It Predict Outcome? J. Nucl. Med., 1991, 32, 382-387.
90. van Royen, E. A.; de Bruïne, J. F.; Hill, T. C.; Vyth, A.; Limburg, M.; Byse, B. L.; O'Leary, D. H.; de Jong, J. M. B. V.; Hijdra, A.; van der Schoot, J. B. Cerebral Blood Flow Imaging with Thallium-201 Diethyldithiocarbamate SPECT. J. Nucl. Med., 1987, 28, 178-183.
91. Sharp, P. F.; Smith, F. W.; Gemmell, H. G.; Lyall, D.; Evans, N. T. S.; Gvozdanovic, D.; Davidson, J.; Tyrell, D. A.; Pickett, R. D.; Neirinckx, R. D. Technetium-99m HM-PAO Stereoisomers as Potential Agents for Imaging Regional Cerebral Blood Flow: Human Volunteer Studies. J. Nucl. Med., 1986, 27, 171-177.
92. Li, H.; Lai, C. S.; Wu, J.; Ho, P. C.; de Vos, D.; Tiekink, E. R. T. Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes. J. Inorg. Biochem., 2007, 101, 809-816.
93. Yang, N.; Sun, H. Biocoordination chemistry of bismuth: Recent advances. Coord. Chem. Rev., 2007, 251, 2354-2366.
94. 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications. Chem. Rev., 2001, 101, 2019-2036.
95. Schmaljohann, J.; Karanikas, G.; Sinzinger, H. Synthesis of cobalt- 55/57-complexes for radiolabelling of platelets as a potential PET imaging agent. J. Labelled Compd. Radiopharm., 2001, 44, 395-403.
96. De Reuck, J.; Santens, P.; Strijckmans, K.; Lemahieu, I. Cobalt-55 positron emission tomography in vascular dementia: significance of white matter changes. J. Neurol. Sci., 2001, 193, 1-6.
97. 55Cobalt complexes with pendant carbohydrates as potential PET imaging agents. Appl. Rad. Isot., 2007, 65, 1303-1308.
98. Brihaye, C.; Guillaume, M.; Lavi, N.; Cogneau, M. Development of a Reliable Hg-195m → Au-195m Generator for the Production of Au-195m, a Short-lived Nuclide for Vascular Imaging. J. Nucl. Med., 1982, 23, 1114-1120.
99. 198Pt. Radiochim. Acta., 2004, 92, 223-228.
100. Kannan, R.; Zambre, A.; Chanda, N.; Kulkarni, R.; Shukla, R.; Katti, K.; Upendran, A.; Cutler, C.; Boote, E.; Katti, K. V. Functionalized radioactive gold nanoparticles in tumor therapy. Wiley. Interdiscip. Rev. Nanomed. Nanobiotechnol., 2011.
101. Molho, P.; Verrier, P.; Stieltjes, N.; Schacher, J. M.; Ounnoughène, N.; Vassilieff, D.; Menkes, C. J.; Sultan, Y. A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis. Haemophilia., 1999, 5, 115-123.
102. Ronconi, L.; Giovagnini, L.; Marzano, C.; Bettìo, F.; Graziani, R.; Pilloni, G.; Fregona, D. Gold Dithiocarbamate Derivatives as Potential Antineoplastic Agents: Design, Spectroscopic Properties, and in Vitro Antitumor Activity. Inorg. Chem., 2005, 44, 1867-1881.
103. Ronconi, L.; Marzano, C.; Zanello, P.; Corsini, M.; Miolo, G.; Maccà, C.; Trevisan, A.; Fregona, D. Gold(III) Dithiocarbamate Derivatives for the Treatment of Cancer: Solution Chemistry, DNA Binding, and Hemolytic Properties. J. Med. Chem., 2006, 49, 1648-1657.